Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Combining fat grafts with botulinum toxin helps improve Raynaud's symptoms.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

N-acetyl-GED may help prevent and partially reverse a process that leads to scarring hair loss.

Microneedle delivery of a special collagen shows promise for treating hair loss.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

PRP and CGF treatments help with hair growth and density in androgenetic alopecia.

Scalp tissue micrografts can effectively treat hair loss by increasing hair density and thickness.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

FGF18 treatment during hair's resting phase can protect against hair loss from radiation.

A parasite molecule can speed up skin healing and reduce scarring.

Corticosteroid injections for hair loss may cause eye problems, so caution is needed.

New antiscarring strategies show promise, including drugs, stem cells, and improved surgical techniques.

A rare scalp condition, cutis verticis gyrata, was found in a woman with primary scarring alopecia.

Combining anti-androgenic, anti-inflammatory, and anti-fibrotic treatments may improve hair loss outcomes, but more testing is needed.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

The 6-year-old Somalian girl fully recovered from her symptoms after successful surgery and treatment.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Kang'ai injection with FLO chemotherapy improves effectiveness and quality of life in advanced gastric cancer patients.

CCCA in women of African ancestry may be caused by PADI3 gene mutations and intense hair grooming.

Glycyrrhizin may help regrow hair by activating a specific pathway.

The hydrogel helps treat hair loss by reducing harmful molecules and improving blood flow to hair follicles.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Combining microneedling with glycosaminoglycan lotion may improve hair growth in mild androgenetic alopecia.

CCCA may be caused by both hair traction and an immune response.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

Androgenetic alopecia requires a personalized treatment plan and psychological support to improve quality of life.

Practitioners treating hair loss need better education and resources to overcome challenges like commercial bias and ethical dilemmas.

IVIG therapy was linked to hair regrowth in two patients with hair loss, but it's not recommended due to its risks and costs.